You are reading a single comment by @Bettini and its replies. Click here to read the full conversation.
  • "In this study, aspirin, as compared with placebo, did not significantly reduce the rate of recurrence of venous thromboembolism but resulted in a significant reduction in the rate of major vascular events, with improved net clinical benefit. These results substantiate earlier evidence of a therapeutic benefit of aspirin when it is given to patients after initial anticoagulant therapy for a first episode of unprovoked venous thromboembolism."

  • I spent an unhealthy amount of time reading up on DVT online after suffering mine, I couldn't find anything that robustly gave an opinion on aspirin (there were limitations with all the studies). From what I understand, the other potential complications from medium- to long-term use of aspirin after a vascular could outweigh the slightly reduced risk of vascular "events".

    I've had the Anticoagulation clinic at St George's hospital recommended if you can get a referral.

About

Avatar for Bettini @Bettini started